Reconstructing the portal vein through a posterior pancreatic tunnel: New choice for portal vein thrombosis during liver transplantation

Table 1 Basic demographics and clinical data of cases with portal vein thrombosis (n = 7)

	Gender	Age	Diagnosis	Operation time (s)	Anhepatic stage (s)	Intraoperative blood loss (mL)	Transfusion of red blood cell suspension (U)	Cold ischemia time (s)	Outcome
Case 1	Male	65	HBV-related decompensated liver cirrhosis, HCC	648	34	1300	10	510	Survival
Case 2	Male	48	HBV-related decompensated liver cirrhosis	756	31	1000	6	480	Survival
Case 3	Male	38	HBV-related decompensated liver cirrhosis	564	35	800	0	390	Death
Case 4	Female	64	HBV-related decompensated liver cirrhosis, HCC	585	25	600	0	360	Survival
Case 5	Male	57	HBV-related decompensated liver cirrhosis, HCC	583	47	600	0	360	Survival
Case 6	Male	54	HBV-related decompensated liver cirrhosis	491	30	500	0	360	Survival
Case 7	Male	51	HBV-related decompensated liver cirrhosis, HCC	625	34	3000	20	360	Survival

HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma.

Table 2 Vascular anatomical changes in the portal vein system of cases with portal vein thrombosis (n = 7)

Case	Left gastric vein (coronary vein)				Esophagogastric fundus vein		Superior mesenteric vein		Splenic vein		Shunt situation
	Drain into the main portal vein	Drain into the confluence of SMV and SpV	Drain into SpV	Maximum diameter of the blood vessel (mm)	Degree of varicose veins	History of upper gastrointestinal bleeding	With or without thrombus	Maximum diameter (mm)	With or without thrombus	Maximum diameter (mm)	With or without splenorenal shunt	Maximum diameter of the shunt (mm)	With or without umbilical vein opening
1	Yes			30	Severe	Yes	No	18.8	No	21.3	Yes	21	No
2			Yes	10.4	Severe	Yes	Yes	17	No	14.2	Yes	24	Yes
3			Yes	24.2	Severe	Yes	No	15.4	No	12.4	Yes	15.7	No
4			Yes	13.8	Severe	Yes	Yes	10.8	No	10.5	Yes	17.3	No
5	Yes			5.9	Severe	No	No	16.4	No	12.5	Yes	11.2	Yes
6	Yes			6.9	Mild	No	No	11	No	18.4	Yes	15.6	No
7		Yes		8.2	Severe	Yes	No	13.1	No	17.1	Yes	7.6	No

Maximum vessel diameter is measured based on contrast-enhanced computed tomography. SMV: Superior mesenteric vein; SpV: Splenic vein.

Table 3 Laboratory examination indicators on postoperative day 7

	ALB (g/L)	TB (μmol/L)	DB (μmol/L)	ALT (U/L)	AST (U/L)	GGT (U/L)	PT (s)	INR
Case 1	32	98	52	111	43	78	20.4	1.72
Case 2	31.4	11.2	4.9	49	24	85	16.6	1.36
Case 3	38.1	27.8	18.3	204	63	236	18.9	1.61
Case 4	35.1	35.1	22.8	224	175	741	16.4	1.30
Case 5	35.3	39.5	23.1	169	41	89	15.9	1.25
Case 6	50	26.8	14.7	329	62	355	14.8	1.19
Case 7	35	20.1	13.5	48	20	328	15.4	1.21

ALB: Albumin; TB: Total bilirubin; DB: Direct bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; PT: Prothrombin time; INR: International normalized ratio.

Table 4 Laboratory examination indicators on postoperative day 14

	ALB (g/L)	TB (μmol/L)	DB (μmol/L)	ALT (U/L)	AST (U/L)	GGT (U/L)	PT (s)	INR
Case 1	33	66	37	58	21	128	17.6	1.42
Case 2	38.3	12.1	5.2	35	15	75	14	1.09
Case 3	42.1	567	226	246	115	232	52.2	6.0
Case 4	34.3	80	54	135	87	677	15.1	1.18
Case 5	39.1	24.2	13.2	27	21	39	14	1.20
Case 6	39.8	13.8	11.2	57	53	140	13.6	1.12
Case 7	34.5	13.8	8.6	37	15	238	14.7	1.14

ALB: Albumin; TB: Total bilirubin; DB: Direct bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; PT: Prothrombin time; INR: International normalized ratio.